Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Peter Dogterom, Robert Riesenberg, Rik de Greef, Justin Dennie, Martin Johnson, Venkatesh Pilla Reddy, André MM Miltenburg, Robert L Findling, Abhijeet Jakate, Timothy J Carrothers & Matthew D Troyer. (2018) Asenapine pharmacokinetics and tolerability in a pediatric population. Drug Design, Development and Therapy 12, pages 2677-2693.
Read now
Read now
Bernardo Dell’Osso, Laura Cremaschi, Maria Carlotta Palazzo, Gregorio Spagnolin, Alma Cattaneo, Benedetta Grancini, Matteo Maggi & Alfredo Carlo Altamura. (2014) Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series. Expert Opinion on Drug Safety 13:9, pages 1199-1208.
Read now
Read now
Leslie Citrome. (2014)
Asenapine review, part II: clinical efficacy, safety and tolerability. Expert Opinion on Drug Safety 13:6, pages 803-830.
Read now
Read now
Marc De Hert, Johan Detraux & Joseph Peuskens. (2014) Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review. Expert Opinion on Drug Safety 13:5, pages 605-624.
Read now
Read now
Jose de Leon, Vincenza Santoro, Concetta D'Arrigo & Edoardo Spina. (2012) Interactions between antiepileptics and second-generation antipsychotics. Expert Opinion on Drug Metabolism & Toxicology 8:3, pages 311-334.
Read now
Read now
Articles from other publishers (13)
Kirsten Schmerder & Nadja Freund. 2023. Psychiatric Vulnerability, Mood, and Anxiety Disorders. Psychiatric Vulnerability, Mood, and Anxiety Disorders
233
277
.
Sona Aliyeva, Sakine Atila Karaca, Alper Uğur, Arın Gül Dal Poçan & Duygu Yeniceli Uğur. (2020) A novel capillary electrophoresis method for the quantification of asenapine in pharmaceuticals using Box-Behnken design. Chemical Papers 74:12, pages 4443-4451.
Crossref
Crossref
Nirav P. Patel, Mallika Sanyal, Naveen Sharma, Dinesh S. Patel, Pranav S. Shrivastav & Bhavin N. Patel. (2018) Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS. Journal of Pharmaceutical Analysis 8:5, pages 341-347.
Crossref
Crossref
Andrea Aguglia, Ludovico Mineo, Alessandro Rodolico, Maria S. Signorelli & Eugenio Aguglia. (2018) Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder. International Clinical Psychopharmacology 33:3, pages 121-130.
Crossref
Crossref
Yawen Jiang, Jeffrey S. McCombs & Susie H. Park. (2017) A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS Drugs 31:4, pages 319-326.
Crossref
Crossref
Sergio De Filippis, Ilaria Cuomo, Georgios D. Kotzalidis, Daniela Pucci, Pietro Zingaretti, Raffaella Porrari, Camilla Fini, Paola Motta, Matteo Caloro & Paolo Girardi. (2016) Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study. Therapeutic Advances in Psychopharmacology 7:2, pages 67-77.
Crossref
Crossref
R.W. Logan & C.A. McClung. (2016) Animal models of bipolar mania: The past, present and future. Neuroscience 321, pages 163-188.
Crossref
Crossref
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Crossref
Ludovic Samalin, Thomas Charpeaud & Pierre-Michel Llorca. (2012) Asenapine in bipolar I disorder: evidence and place in patient management. Therapeutic Advances in Chronic Disease 4:1, pages 5-14.
Crossref
Crossref
Lisbeth Patteet, Manuel Morrens, Kristof E. Maudens, Peter Niemegeers, Bernard Sabbe & Hugo Neels. (2012) Therapeutic Drug Monitoring of Common Antipsychotics. Therapeutic Drug Monitoring 34:6, pages 629-651.
Crossref
Crossref
Mohammed Shahid. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs
14
31
.
Debbi A. Morrissette & Stephen M. Stahl. (2011) Affective symptoms in schizophrenia. Drug Discovery Today: Therapeutic Strategies 8:1-2, pages 3-9.
Crossref
Crossref
Richard C McEachin. (2011) Overlap of genetic influences in phenotypes classically categorized as psychiatric vs medical disorders. World Journal of Medical Genetics 1:1, pages 4.
Crossref
Crossref